In December 2020, the FDA approved the Osseoanchored Prostheses for the Rehabilitation of Amputees (OPRA) Implant System—the first implant system in the United States for transfemoral amputees who have difficulty using a conventional prosthesis. OPRA had been previously available and marketed under a humanitarian device exemption (HDE) since 2015.…